| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35d3abd84cb49a7ff3804be4a27fa6a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77138b837856ebf8ab7a5fddced94f23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4ac3d266bde9bbf5ccd833a951d82ec |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
2012-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c581513d63cc3c33c84b1d351d2e0fec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cf7bc7866ec93776333999f2e8b58ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6162af903c98cac171c402b0e0d59c1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb9f1c028b91621242f7e6f898f0531e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0708f4af283f6e50c52e6b5782195d2 |
| publicationDate |
2013-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2856229-A1 |
| titleOfInvention |
Methods of treatment with deferiprone |
| abstract |
The current application is directed to methods of treating or ameliorating myocardial ischemia, an acute coronary event, and a myocardial reperfusion injury comprising administering a therapeutically effective amount of deferiprone or a pharmaceutically acceptable salt thereof to a patient in need thereof. The application is also directed to reducing the risk for myocardial reperfusion injury as well as promoting the beneficial remodeling of cardiac tissue in a patient, comprising administering a therapeutically effective amount of deferiprone or a pharmaceutically acceptable salt thereof to a patient before, during or after reperfusion therapy. The application also includes methods of selecting a patient for treatment of reperfusion injury and subsequently treating the selected patient. |
| priorityDate |
2011-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |